Celanese Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Celanese ha aumentado sus beneficios a una tasa media anual de 9.3%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 9.8% anual. Los ingresos han ido creciendo a una tasa media de 14.5% al año. La rentabilidad financiera de Celanese es de 14.3%, y sus márgenes netos son de 10.5%.
Información clave
9.3%
Tasa de crecimiento de los beneficios
11.3%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 12.9% |
| Tasa de crecimiento de los ingresos | 14.5% |
| Rentabilidad financiera | 14.3% |
| Margen neto | 10.5% |
| Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Celanese Corporation: The Pain Of Leverage
Nov 12Celanese Corporation Just Missed EPS By 61%: Here's What Analysts Think Will Happen Next
Nov 06
Celanese: Sold In January 2024, Back In Again With A 'Buy'
Oct 21Celanese (NYSE:CE) Is Due To Pay A Dividend Of $0.70
Oct 21Here's Why Celanese (NYSE:CE) Has A Meaningful Debt Burden
Sep 27Celanese Corporation's (NYSE:CE) Earnings Are Not Doing Enough For Some Investors
Aug 15Celanese Corporation: Margin Expansion Story Doesn't Offset Leverage Risks
Aug 07Celanese (NYSE:CE) Is Paying Out A Dividend Of $0.70
Jul 21Is Celanese (NYSE:CE) Using Too Much Debt?
Jun 26Is Celanese Corporation (NYSE:CE) Potentially Undervalued?
Jun 08Celanese: Debt Front Loaded, Performance Still On Drawing Board
May 23Celanese's (NYSE:CE) Attractive Earnings Are Not All Good News For Shareholders
May 21Shareholders May Find It Hard To Justify A Pay Rise For Celanese Corporation's (NYSE:CE) CEO This Year
May 07Celanese's (NYSE:CE) Dividend Will Be $0.70
Apr 22Celanese Corporation's (NYSE:CE) Business And Shares Still Trailing The Market
Apr 09Celanese: Appetite For Acquisitions Remains
Mar 11Here's Why Celanese (NYSE:CE) Has A Meaningful Debt Burden
Feb 29Celanese (NYSE:CE) Will Pay A Dividend Of $0.70
Feb 11Celanese Corporation (NYSE:CE) Shares Could Be 30% Below Their Intrinsic Value Estimate
Jan 25Is Now The Time To Look At Buying Celanese Corporation (NYSE:CE)?
Jan 07Celanese Corporation: A Sign Of Relief
Dec 27Celanese Corporation's (NYSE:CE) Earnings Are Not Doing Enough For Some Investors
Dec 20Celanese (NYSE:CE) Takes On Some Risk With Its Use Of Debt
Nov 09Celanese's (NYSE:CE) Dividend Will Be $0.70
Oct 22Celanese: Highly Leveraged Specialty Materials Leader
Oct 18Celanese Corporation (NYSE:CE) Shares Could Be 39% Below Their Intrinsic Value Estimate
Oct 17Is It Too Late To Consider Buying Celanese Corporation (NYSE:CE)?
Sep 29Celanese: Business Is So Bad They're Dusting Off COVID Operating Model
Aug 09Is Celanese (NYSE:CE) A Risky Investment?
Jul 30Is Celanese Corporation (NYSE:CE) Trading At A 33% Discount?
Jul 12Celanese: A Bad Deal Sinking The Stock
Jul 07Should You Think About Buying Celanese Corporation (NYSE:CE) Now?
Jun 23Celanese: Clear Lake Is A Catalyst, Rewards Outweigh Risks
Jun 22Is Celanese (NYSE:CE) A Risky Investment?
Apr 22An Intrinsic Calculation For Celanese Corporation (NYSE:CE) Suggests It's 30% Undervalued
Apr 04What Is Celanese Corporation's (NYSE:CE) Share Price Doing?
Mar 20Celanese, Mitsui launch new Food Ingredients venture, extend Fairway Methanol JV
Feb 23Celanese (NYSE:CE) Is Increasing Its Dividend To $0.70
Feb 12Celanese expanding portfolio of sustainable products across Acetyl Chain
Feb 08Is Celanese (NYSE:CE) Using Too Much Debt?
Jan 10Is Celanese Corporation (NYSE:CE) Trading At A 46% Discount?
Dec 26Celanese: The Seed Is Planted, Now Watch Returns Grow
Dec 16What Is Celanese Corporation's (NYSE:CE) Share Price Doing?
Dec 11Celanese Non-GAAP EPS of $3.94 misses by $0.03, revenue of $2.3B beats by $40M
Nov 03Celanese (NYSE:CE) Is Increasing Its Dividend To $0.70
Oct 23Desglose de ingresos y gastos
Cómo gana y gasta dinero Celanese. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 10,479 | 1,099 | 1,100 | 131 |
| 30 Jun 24 | 10,554 | 1,933 | 1,100 | 131 |
| 31 Mar 24 | 10,698 | 1,996 | 1,123 | 138 |
| 31 Dec 23 | 10,940 | 1,969 | 1,144 | 146 |
| 30 Sep 23 | 10,719 | 2,033 | 1,014 | 151 |
| 30 Jun 23 | 10,297 | 1,273 | 928 | 144 |
| 31 Mar 23 | 9,988 | 1,494 | 824 | 130 |
| 31 Dec 22 | 9,673 | 1,902 | 690 | 112 |
| 30 Sep 22 | 9,600 | 1,662 | 658 | 98 |
| 30 Jun 22 | 9,565 | 1,989 | 627 | 94 |
| 31 Mar 22 | 9,277 | 2,091 | 578 | 90 |
| 31 Dec 21 | 8,537 | 1,912 | 527 | 86 |
| 30 Sep 21 | 7,853 | 2,837 | 552 | 83 |
| 30 Jun 21 | 6,998 | 2,527 | 502 | 81 |
| 31 Mar 21 | 5,993 | 2,095 | 466 | 77 |
| 31 Dec 20 | 5,655 | 1,997 | 464 | 74 |
| 30 Sep 20 | 5,496 | 586 | 457 | 71 |
| 30 Jun 20 | 5,671 | 645 | 482 | 69 |
| 31 Mar 20 | 6,070 | 745 | 496 | 68 |
| 31 Dec 19 | 6,297 | 858 | 502 | 67 |
| 30 Sep 19 | 6,554 | 912 | 578 | 68 |
| 30 Jun 19 | 6,739 | 1,051 | 579 | 69 |
| 31 Mar 19 | 6,991 | 1,185 | 588 | 70 |
| 31 Dec 18 | 7,155 | 1,212 | 606 | 72 |
| 30 Sep 18 | 7,059 | 1,320 | 500 | 74 |
| 30 Jun 18 | 6,854 | 1,143 | 506 | 75 |
| 31 Mar 18 | 6,520 | 1,038 | 491 | 74 |
| 31 Dec 17 | 6,140 | 856 | 451 | 73 |
| 30 Sep 17 | 5,858 | 812 | 470 | 73 |
| 30 Jun 17 | 5,615 | 847 | 441 | 74 |
| 31 Mar 17 | 5,456 | 829 | 417 | 76 |
| 31 Dec 16 | 5,389 | 902 | 416 | 78 |
| 30 Sep 16 | 5,412 | 444 | 441 | 79 |
| 30 Jun 16 | 5,502 | 340 | 453 | 78 |
| 31 Mar 16 | 5,628 | 326 | 488 | 79 |
| 31 Dec 15 | 5,674 | 306 | 506 | 80 |
| 30 Sep 15 | 5,899 | 522 | 714 | 77 |
| 30 Jun 15 | 6,255 | 619 | 739 | 80 |
| 31 Mar 15 | 6,547 | 671 | 752 | 84 |
| 31 Dec 14 | 6,802 | 631 | 758 | 86 |
| 30 Sep 14 | 6,859 | 1,369 | 336 | 80 |
| 30 Jun 14 | 6,726 | 1,282 | 315 | 82 |
| 31 Mar 14 | 6,610 | 1,156 | 309 | 81 |
| 31 Dec 13 | 6,510 | 1,101 | 311 | 85 |
Ingresos de calidad: CE tiene una única gran pérdida de $226.0M que afecta a sus resultados financieros de los últimos 12 meses de 30th September, 2024.
Margen de beneficios creciente: Los actuales márgenes de beneficio(10.5%) de CE son inferiores a los del año pasado (19%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de CE han crecido un 9.3% al año en los últimos 5 años.
Acelerando crecimiento: CE ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: CE tuvo un crecimiento negativo de los beneficios (-45.9%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-0.5%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de CE (14.3%) se considera baja.